MA56105A - Ester isopropylique d'acide [((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-acétique pour traiter la toux chronique - Google Patents

Ester isopropylique d'acide [((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-acétique pour traiter la toux chronique

Info

Publication number
MA56105A
MA56105A MA056105A MA56105A MA56105A MA 56105 A MA56105 A MA 56105A MA 056105 A MA056105 A MA 056105A MA 56105 A MA56105 A MA 56105A MA 56105 A MA56105 A MA 56105A
Authority
MA
Morocco
Prior art keywords
isopropyl
cyclohexanecarbonyl
amino
methyl
treatment
Prior art date
Application number
MA056105A
Other languages
English (en)
Other versions
MA56105B1 (fr
Inventor
Olivier Poirot
Ashley Woodcock
Original Assignee
Axalbion Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axalbion Sa filed Critical Axalbion Sa
Publication of MA56105A publication Critical patent/MA56105A/fr
Publication of MA56105B1 publication Critical patent/MA56105B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA56105A 2019-06-10 2020-06-10 Ester isopropylique d'acide [((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-acétique pour traiter la toux chronique MA56105B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1908219.7A GB201908219D0 (en) 2019-06-10 2019-06-10 Therapeutic use of a compound
PCT/EP2020/066065 WO2020249607A1 (fr) 2019-06-10 2020-06-10 Ester isopropylique d'acide [((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-acétique pour traiter la toux chronique

Publications (2)

Publication Number Publication Date
MA56105A true MA56105A (fr) 2022-04-13
MA56105B1 MA56105B1 (fr) 2024-03-29

Family

ID=67386245

Family Applications (1)

Application Number Title Priority Date Filing Date
MA56105A MA56105B1 (fr) 2019-06-10 2020-06-10 Ester isopropylique d'acide [((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-acétique pour traiter la toux chronique

Country Status (32)

Country Link
US (1) US12167995B2 (fr)
EP (2) EP4342533A3 (fr)
JP (1) JP7181426B2 (fr)
KR (2) KR20250111405A (fr)
CN (1) CN114007601B (fr)
AU (2) AU2020293622B2 (fr)
BR (1) BR112021024927A2 (fr)
CA (1) CA3143094C (fr)
CL (1) CL2021003301A1 (fr)
DK (1) DK3980003T3 (fr)
EA (1) EA202193006A1 (fr)
ES (1) ES2973546T3 (fr)
FI (1) FI3980003T3 (fr)
GB (1) GB201908219D0 (fr)
HR (1) HRP20240312T1 (fr)
HU (1) HUE065581T2 (fr)
IL (1) IL288874A (fr)
JO (1) JOP20210315B1 (fr)
LT (1) LT3980003T (fr)
MA (1) MA56105B1 (fr)
MD (1) MD3980003T2 (fr)
MX (1) MX2021014761A (fr)
MY (1) MY209641A (fr)
NZ (1) NZ784012A (fr)
PH (1) PH12021553093A1 (fr)
PL (1) PL3980003T3 (fr)
PT (1) PT3980003T (fr)
RS (1) RS65224B1 (fr)
SI (1) SI3980003T1 (fr)
SM (1) SMT202400198T1 (fr)
WO (1) WO2020249607A1 (fr)
ZA (1) ZA202109580B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250288583A1 (en) * 2024-03-14 2025-09-18 Edward Tak Wei Treatment of Mucus Hypersecretion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189760B2 (en) * 2004-04-02 2007-03-13 Millennium Specialty Chemicals Physiological cooling compositions containing highly purified ethyl ester of N-[[5-methyl-2-(1-methylethyl) cyclohexyl] carbonyl]glycine
EA200602166A1 (ru) * 2004-06-22 2007-06-29 Басф Акциенгезельшафт Применение 6-(2-толил)триазолопиримидинов в качестве фунгицидов, новые 6-(2-толил)триазолопиримидины, способ их получения и их применение для борьбы с патогенными грибами, а также содержащие их средства
AU2006228280B2 (en) * 2005-03-29 2012-08-30 Axalbion Sa N-alkylcarbonyl-amino acid ester and N-alkylcarbonyl-amino lactone compounds and their use
CN103339103B (zh) * 2010-12-06 2015-06-17 魏德烽 [((1r,2s,5r)-2-异丙基-5-甲基-环己烷羰基)-氨基]乙酸异丙酯和相关化合物及它们在治疗中的应用
US8426463B2 (en) 2011-04-04 2013-04-23 Edward T. Wei [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
CA2861496A1 (fr) * 2012-02-06 2013-08-15 Glaxosmithkline Intellectual Property (No.2) Limited Inhibiteurs de la pi3k pour traiter la toux
WO2015059433A1 (fr) * 2013-10-22 2015-04-30 Edward Tak Wei 1-di(sec-butyl)-phosphinoyl-pentane (dapa-2-5) en tant que médicament topique pour le traitement de l'inconfort du tissu épithélial stratifié non kératinisé
RS65492B1 (sr) 2017-07-24 2024-05-31 Novartis Ag Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp
EA202092678A1 (ru) 2018-05-15 2021-04-12 Байер Акциенгезельшафт 1,3-тиазол-2-ил-замещенные бензамиды для лечения заболеваний, ассоциированных с сенситизацией нервных волокон

Also Published As

Publication number Publication date
JOP20210315A1 (ar) 2023-01-30
KR102836060B1 (ko) 2025-07-18
EA202193006A1 (ru) 2022-03-17
CN114007601B (zh) 2025-03-07
LT3980003T (lt) 2024-03-12
NZ784012A (en) 2025-11-28
MX2021014761A (es) 2022-02-21
JP7181426B2 (ja) 2022-11-30
AU2020293622B2 (en) 2025-04-03
WO2020249607A1 (fr) 2020-12-17
JP2022534321A (ja) 2022-07-28
ZA202109580B (en) 2023-04-26
SMT202400198T1 (it) 2024-07-09
FI3980003T3 (fi) 2024-03-01
HRP20240312T1 (hr) 2024-05-10
DK3980003T3 (da) 2024-02-19
IL288874A (en) 2022-02-01
BR112021024927A2 (pt) 2022-01-18
EP4342533A2 (fr) 2024-03-27
MY209641A (en) 2025-07-28
MD3980003T2 (ro) 2024-05-31
AU2025205040A1 (en) 2025-07-24
PL3980003T3 (pl) 2024-05-20
CN114007601A (zh) 2022-02-01
HUE065581T2 (hu) 2024-06-28
PT3980003T (pt) 2024-03-05
EP3980003A1 (fr) 2022-04-13
ES2973546T3 (es) 2024-06-20
KR20250111405A (ko) 2025-07-22
MA56105B1 (fr) 2024-03-29
RS65224B1 (sr) 2024-03-29
CA3143094A1 (fr) 2020-12-17
SI3980003T1 (sl) 2024-05-31
CA3143094C (fr) 2023-11-07
US12167995B2 (en) 2024-12-17
US20220265594A1 (en) 2022-08-25
PH12021553093A1 (en) 2023-08-14
EP4342533A3 (fr) 2024-05-29
JOP20210315B1 (ar) 2024-12-22
GB201908219D0 (en) 2019-07-24
AU2020293622A1 (en) 2022-02-03
KR20220019715A (ko) 2022-02-17
EP3980003B1 (fr) 2023-12-13
CL2021003301A1 (es) 2022-08-19

Similar Documents

Publication Publication Date Title
EP3622080C0 (fr) Procédés améliorés pour la production d'isobutène à partir d'acide 3-méthylcrotonique
EA201270824A1 (ru) Соединения для уменьшения продукции бета-амилоида
EP4053092A4 (fr) Extrait liquide d'acide humique
NZ741093A (en) Compounds, compositions, and methods for modulating cftr
EP3337782A4 (fr) Diacéréine ou ses analogues pour inhibition de l'expression des protéines asc et nlrp3, et/ou de la formation du complexe de l'inflammasome nlrp3
WO2015056237A3 (fr) Purification de protéines
EP3907289A4 (fr) Estérase d'acide chrysanthémique modifiée
EP3849573A4 (fr) Bactériothérapie contre proprionibacterium acnes pour le traitement de l'acné
DOP2014000048A (es) Composiciones farmacéuticas que comprenden un polisacárido y un inhibidor hdac
FR3049601B1 (fr) Procede ameliore de production d'acide (meth)acrylique
EP3317396A4 (fr) Procédé et micro-organisme pour la synthèse d'acide adipique à partir d'acides carboxyliques
EP3423563A4 (fr) Production améliorée d'acide muconique à partir de micro-organismes génétiquement modifiés
EA201890771A1 (ru) Соли и твердые формы монобактамного антибиотика
WO2017077528A3 (fr) Procédés et compositions pharmaceutiques pour le traitement d'inflammations pulmonaires
EP3738948A4 (fr) Procédé de fabrication d'ester d'acide carbonique
EP3804853A4 (fr) Procédé de préparation d'indoxacarb s
EA201391097A1 (ru) СОЕДИНЕНИЯ ДЛЯ СНИЖЕНИЯ ВЫРАБОТКИ β-АМИЛОИДА
MA56105A (fr) Ester isopropylique d'acide [((1r,2s,5r)-2-isopropyl-5-méthyl-cyclohexanecarbonyl)-amino]-acétique pour traiter la toux chronique
JOP20190045A1 (ar) مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
EP3995535A4 (fr) Composition d'ester d'acide phtalique
EP3816148A4 (fr) Procédé d'isomérisation d'acide cyclohexane dicarboxylique
EP3950657A4 (fr) Procédé de production d'acide carboxylique
EP4342931A4 (fr) Dianhydride d'acide
EP3969465A4 (fr) Production d'acide malique
EP3967714A4 (fr) Copolymère d'ester d'acide aminé-alcool vinylique